Sight Sciences, Inc. Cash Flow Statement
SGHT|5 years of annual SEC 10-K data (FY2021-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 5 fiscal years. All figures from audited SEC 10-K filings.
Sight Sciences, Inc. used $22M in operating cash flow and negative free cash flow of $23M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income | -$51.5M | -$55.5M | -$86.2M | -$63.0M | -$34.7M |
| Depreciation & Amortization | $712.0K | $614.0K | $710.0K | $632.0K | $554.0K |
| Operating Cash Flow | -$22.4M | -$47.2M | -$76.0M | -$52.5M | -$32.2M |
| Capital Expenditures | $385.0K | $791.0K | $970.0K | $813.0K | $953.0K |
| Free Cash Flow | -$22.7M | -$48.0M | -$76.9M | -$53.4M | -$33.1M |
| FCF Margin | -28.5% | -59.2% | -107.9% | -109.0% | -119.8% |